Brief: CytRx Corp Says Co Got Patent Covering Use Of Aldoxorubicin For Treatment Of Brain Cancer

LadRx

08/05/2019 14:44

May 8 (Reuters) - CytRx Corp  CYTR.O :
    * CYTRX CORP - GOT PATENT FROM U.S. PATENT AND TRADEMARK
OFFICE
COVERING USE OF ALDOXORUBICIN FOR TREATMENT OF BRAIN CANCER
    * CYTRX CORP - NEW PATENT ISSUED ON MAY 7, 2019 AS U.S.
PATENT NO.
10,278,981, IS TITLED "CYTOTOXIC AGENTS FOR TREATMENT OF CANCER

Source text for Eikon:  ID:nPnbPJBpga 
Further company coverage:  CYTR.O 

 ((Reuters.Briefs@thomsonreuters.com;))